Insider Transactions in Q1 2024 at Tango Therapeutics, Inc. (TNGX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 20
2024
|
Third Rock Ventures Iv, L.P. |
SELL
Open market or private sale
|
Direct |
162,500
-0.84%
|
$1,950,000
$12.0 P/Share
|
|
Feb 07
2024
|
Barbara Weber Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,457
-0.29%
|
$53,484
$12.62 P/Share
|
|
Feb 07
2024
|
Adam Crystal |
SELL
Open market or private sale
|
Direct |
4,083
-3.3%
|
$48,996
$12.62 P/Share
|
|
Feb 07
2024
|
Daniella Beckman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,817
-1.35%
|
$21,804
$12.62 P/Share
|
|
Feb 07
2024
|
Douglas Barry General Counsel |
SELL
Open market or private sale
|
Direct |
1,354
-2.99%
|
$16,248
$12.62 P/Share
|
|
Feb 06
2024
|
Barbara Weber Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,681
-0.3%
|
$56,172
$12.56 P/Share
|
|
Feb 06
2024
|
Adam Crystal |
SELL
Open market or private sale
|
Direct |
4,288
-3.35%
|
$51,456
$12.56 P/Share
|
|
Feb 06
2024
|
Daniella Beckman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,908
-1.4%
|
$22,896
$12.56 P/Share
|
|
Feb 06
2024
|
Douglas Barry General Counsel |
SELL
Open market or private sale
|
Direct |
1,422
-3.04%
|
$17,064
$12.56 P/Share
|
|
Feb 01
2024
|
Daniella Beckman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,413
+50.0%
|
-
|
|
Feb 01
2024
|
Douglas Barry General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
22,859
+50.0%
|
-
|
|
Feb 01
2024
|
Barbara Weber Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
87,168
+50.0%
|
-
|
|
Feb 01
2024
|
Adam Crystal |
BUY
Grant, award, or other acquisition
|
Direct |
46,599
+50.0%
|
-
|